[Prevalence of and risk factors for hepatitis C in blood donors]

Laura Ladrón-de Guevara1, Nicolás Gómez, Mariana Vázquez-Cantarell

  • 1Servicio de Gastroenterología, Centro Médico Nacional 20 de Noviembre, Instituto de Seguridad, Servicios Sociales para los Trabajadores del Estado (ISSSTE), México, D.F. lauraldeg@yahoo.com

Insights

Hepatitis C virus (HCV) prevalence in Mexico City blood donors was 0.84%. Key risk factors included sexual relations with prostitutes, transfusions, cocaine use, dental surgery, and contact with infected individuals.

Area of Science:

  • Hepatology and Virology
  • Epidemiology
  • Public Health

Context:

  • Hepatitis C virus (HCV) poses a significant global health challenge.
  • Blood donation screening is crucial for preventing transfusion-transmitted infections.
  • Understanding local prevalence and risk factors is vital for targeted interventions.

Purpose:

  • To determine the prevalence of Hepatitis C virus (HCV) infection among blood donors.
  • To identify and analyze risk factors associated with HCV infection in this population.

Summary:

  • A case-control study analyzed 41,957 blood donors from 1996-2000.
  • HCV prevalence was 0.84%. Significant risk factors identified included sexual relations with prostitutes, previous transfusions, nasal cocaine use, dental surgery, and contact with infected individuals.
  • A notable finding was that 30% of initially sero-positive donors recalled risk factors upon re-interview.

Impact:

  • Provides essential epidemiological data on HCV in Mexican blood donors.
  • Highlights specific high-risk behaviors and exposures that warrant public health attention.
  • Informs blood bank screening protocols and public health campaigns to reduce HCV transmission.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...